Selexis SA

Selexis is the global leader in cell line development with best-in-class modular technology to translate scientific innovation into life-saving medicines.🇨🇭

[Selexis SA @SelexisSA]

Today is PepTalk's last day. Take the chance to chat without our team as we are coexhibiting with @KBIBiopharma at booth #506!
#PTK23

[Selexis SA @SelexisSA]

Listen to Elodie Pothin, PhD, BD Manager, explain how Selexis can maximize your biotherapeutic success rate and help you achieve your cell line goals.

#CLD #CDMO #biotech #biotechnologyindustry
https://t.co/aMoSiuhyxN

[Selexis SA @SelexisSA]

If #celllinedevelopment is not your area of expertise, you may have a lot of #questions. Have you considered partnering with a CLD #expert? Check out our FAQ and get the expert's answer.
https://t.co/nvqjqaYsEb

[Selexis SA @SelexisSA]

Selexis is at @AntibodyEngIC today! Be sure to schedule a meeting with Jonathan Viola to learn more about why Selexis is the leader in cell line development.
#CLD #Antibody

https://t.co/xLAoaLJDPm

[Selexis SA @SelexisSA]

Sonja Delalu, BD and Licensing Director, discusses the unique services and solutions Selexis provides its #partners to help them #achieve their cell line #goals.

https://t.co/qWcNEu2H0J

[Selexis SA @SelexisSA]

Today is the first day of #BioFIT2022. Elodie Pothin, PhD, our Business Development Manager, is ready to discuss your company's cell line needs. #celllinedevelopment
https://t.co/s48oZ26CyP

[Selexis SA @SelexisSA]

Selexis will be at @AntibodyEngIC next week. Be sure to schedule a meeting with Jonathan Viola to learn more about why Selexis is the leader in cell line development.
#CLD #AntibodyEng

https://t.co/xLAoaM1eGU

[Selexis SA @SelexisSA]

Last week, Séverine Fagète, VP Cell Line Services, presented at #pegseurope a #poster about fed-batch strategies to increase mAb titer by 100% without sacrificing product #quality. Access to the poster and have a look at others in our knowledge center:

https://t.co/1q02mfwEao

[Selexis SA @SelexisSA]

Meet Roland Hecht, PhD, SVP Business Development EU/APAC @KBIBiopharma & Selexis, describing what it is like when cell line development leader Selexis joins forces with KBI, the #CDMO with the best analytical platform worldwide.
https://t.co/FmL89YbkCE

[Selexis SA @SelexisSA]

Selexis will be at #BioFIT2022 next week. Be sure to schedule a meeting with Elodie Pothin to learn more about why Selexis is the leader in cell line development.
#CLD #BIOFIT
https://t.co/s48oZ26CyP

[Selexis SA @SelexisSA]

ICYM - Our cutting-edge science and technical experts provide high quality services developing the best cell lines to global partners.

Discover our state-of-the-art #labs in Geneva, to see why #innovation and #quality are our main drivers.
https://t.co/9ss0tJnVyC

[Selexis SA @SelexisSA]

Today! Dr. Séverine Fagète, VP, presents how Selexis has developed novel hybrid strategies to enable acceptable seeding densities without compromising #quality, or to push #productivity the furthest in order to reduce timelines.
#PEGSEurope
https://t.co/OhnRqOXa9P

[Selexis SA @SelexisSA]

Today! Ghislaine Arib, PhD, is presenting during the Optimizing Expression Platforms track about the #Selexis FISH platform for industrial-scale karyotyping and monoclonality assessment.
#PEGS #CDMO #regulatoryaffairs #PEGSEurope

[Selexis SA @SelexisSA]

Our cutting-edge labs and technical experts provide high quality services developing the best cell lines to global partners.

Discover our state-of-the-art #laboratory in Geneva, to see why #innovation and #quality are our main drivers.
https://t.co/9ss0tJnVyC

[Selexis SA @SelexisSA]

Don't miss this #PEGSEurope session by Ghislaine Arib, PhD, next week during the Optimizing Expression Platforms track. Be among the firsts to hear about our unique FISH platform for industrial-scale karyotyping and monoclonality assessment. #PEGS #CDMO #regulatoryaffairs 🔬

[Selexis SA @SelexisSA]

Selexis will be at #PEGSEurope next week! Séverine Fagète, VP Cell Line Services, will present how Selexis developed novel hybrid strategies for acceptable seeding densities w/out compromising productivity, or to push the productivity to reduce timelines.
https://t.co/OhnRqOXa9P

[Selexis SA @SelexisSA]

Listen to Regine Brokamp, COO, discuss Selexis' reliable, robust, and on-time cell line development service results in both recurring and new partners year-after-year.
https://t.co/Z3qYJGg2pI

[Selexis SA @SelexisSA]

Selexis is gearing up for #PEGSEurope Nov 14-16 in #Barcelona. Meet the Selexis and KBI team to discuss your #CellLine needs.
https://t.co/OhnRqOXa9P

[Selexis SA @SelexisSA]

Today is the first day of CPHI in Frankfurt, Germany. Schedule a meeting with Roland Hecht, PhD, CBO, and Sonja Delalu, PhD, Director of BD & Licensing at booth 91J52 and learn why #Selexis is the leader in #CellLine development #cphi

https://t.co/5Ti2YTF2jT

[Selexis SA @SelexisSA]

Abdelaziz Toumi, Ph.D., today joins @KBIBiopharma and Selexis SA as Chief Business Officer. Toumi brings more than two decades of global expertise in biotech, pharmaceutical, and CDMO industries, demonstrating visionary and strategic leadership.